Sundaram Preethi
Insider CIK 1872422 · CPRX Chief Strategy Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| CPRX CATALYST PHARMACEUTICALS, | D To issuer deriv | 2026-07-15 | 2026-07-17 | 32,257 | — | $0 | 0 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | D To issuer deriv | 2026-07-15 | 2026-07-17 | 11,206 | — | $0 | 0 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | D To issuer deriv | 2026-07-15 | 2026-07-17 | 6,855 | — | $0 | 0 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | D To issuer deriv | 2026-07-15 | 2026-07-17 | 106,873 | — | $0 | 0 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | D To issuer deriv | 2026-07-15 | 2026-07-17 | 137,553 | — | $0 | 0 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | D To issuer deriv | 2026-07-15 | 2026-07-17 | 143,193 | — | $0 | 0 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | D To issuer deriv | 2026-07-15 | 2026-07-17 | 68,000 | — | $0 | 0 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | D To issuer deriv | 2026-07-15 | 2026-07-17 | 67,500 | — | $0 | 0 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | D To issuer deriv | 2026-07-15 | 2026-07-17 | 225,000 | — | $0 | 0 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | D To issuer | 2026-07-15 | 2026-07-17 | 54,804 | $31.50 | $1.73M | 0 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise deriv | 2025-12-29 | 2025-12-30 | 6,667 | — | $0 | 798,437 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | F Tax w/h | 2025-12-29 | 2025-12-30 | 2,369 | — | $0 | 54,804 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise | 2025-12-29 | 2025-12-30 | 6,667 | — | $0 | 57,173 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise deriv | 2025-12-08 | 2025-12-10 | 6,855 | — | $0 | 805,104 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise | 2025-12-08 | 2025-12-10 | 6,855 | — | $0 | 52,175 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | F Tax w/h | 2025-12-08 | 2025-12-10 | 1,669 | — | $0 | 50,506 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise deriv | 2025-11-21 | 2025-11-24 | 5,603 | — | $0 | 811,959 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | F Tax w/h | 2025-11-21 | 2025-11-24 | 1,364 | — | $0 | 45,320 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise | 2025-11-21 | 2025-11-24 | 5,603 | — | $0 | 46,684 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | A Award deriv | 2025-11-20 | 2025-11-24 | 32,257 | — | $0 | 817,562 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | A Award deriv | 2025-11-20 | 2025-11-24 | 106,873 | — | $0 | 785,305 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | S Sale | 2025-06-11 | 2025-06-12 | 1,600 | $26.42 | $42.3K | 41,081 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | S Sale | 2025-06-10 | 2025-06-12 | 2,324 | $26.41 | $61.4K | 42,681 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise deriv | 2025-02-14 | 2025-02-19 | 16,667 | — | $0 | 678,432 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise | 2025-02-14 | 2025-02-19 | 16,667 | — | $0 | 50,970 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | F Tax w/h | 2025-02-14 | 2025-02-19 | 5,965 | — | $0 | 45,005 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise deriv | 2024-12-27 | 2024-12-31 | 6,667 | — | $0 | 695,099 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise | 2024-12-27 | 2024-12-31 | 6,667 | — | $0 | 36,648 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | F Tax w/h | 2024-12-27 | 2024-12-31 | 2,345 | — | $0 | 34,303 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise deriv | 2024-12-09 | 2024-12-11 | 6,855 | — | $0 | 701,766 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | F Tax w/h | 2024-12-09 | 2024-12-11 | 2,415 | — | $0 | 29,981 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise | 2024-12-09 | 2024-12-11 | 6,855 | — | $0 | 32,396 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | A Award deriv | 2024-11-21 | 2024-11-25 | 16,809 | — | $0 | 708,621 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | A Award deriv | 2024-11-21 | 2024-11-25 | 137,553 | — | $0 | 691,812 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise deriv | 2024-02-15 | 2024-02-16 | 16,667 | — | $0 | 554,259 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | F Tax w/h | 2024-02-15 | 2024-02-16 | 6,025 | — | $0 | 25,541 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise | 2024-02-15 | 2024-02-16 | 16,667 | — | $0 | 31,566 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise deriv | 2023-12-27 | 2023-12-29 | 6,666 | — | $0 | 570,926 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | F Tax w/h | 2023-12-27 | 2023-12-29 | 2,409 | — | $0 | 14,899 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise | 2023-12-27 | 2023-12-29 | 6,666 | — | $0 | 17,308 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | A Award deriv | 2023-12-08 | 2023-12-12 | 143,193 | — | $0 | 557,027 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | A Award deriv | 2023-12-08 | 2023-12-12 | 20,565 | — | $0 | 577,592 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise deriv | 2023-02-15 | 2023-02-17 | 16,666 | — | $0 | 413,834 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise | 2023-02-15 | 2023-02-17 | 16,666 | — | $0 | 16,666 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | F Tax w/h | 2023-02-15 | 2023-02-17 | 6,024 | — | $0 | 10,642 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | A Award deriv | 2022-12-27 | 2022-12-29 | 68,000 | — | $0 | 410,500 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | A Award deriv | 2022-12-27 | 2022-12-29 | 20,000 | — | $0 | 430,500 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise deriv | 2022-11-11 | 2022-11-15 | 56,786 | — | $0 | 342,500 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | S Sale | 2022-11-11 | 2022-11-15 | 28,393 | $16.50 | $468.5K | 0 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | S Sale | 2022-11-11 | 2022-11-15 | 28,393 | $16.25 | $461.4K | 28,393 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise | 2022-11-11 | 2022-11-15 | 56,786 | $5.49 | $311.8K | 56,786 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise deriv | 2022-09-15 | 2022-09-16 | 18,214 | — | $0 | 399,286 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise | 2022-09-15 | 2022-09-16 | 18,214 | $5.49 | $100.0K | 18,214 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | S Sale | 2022-09-15 | 2022-09-16 | 18,214 | $14.49 | $263.9K | 0 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | A Award deriv | 2022-02-14 | 2022-02-16 | 50,000 | — | $0 | 417,500 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | A Award deriv | 2021-12-28 | 2021-12-30 | 67,500 | — | $0 | 367,500 | SEC↗ |